Evan Scott
About
Scott, renowned for his groundbreaking work in nanotechnology to address cancer, glaucoma, heart disease, and other conditions, is poised to join the Biomedical Engineering Department at UVA. He leads the Institute for Nanoscale Scientific and Technological Advanced Research (nanoSTAR) as part of the launch of the Paul and Diane Manning Institute of Biotechnology.
Scott earned his Ph.D. from Washington University in St. Louis in 2009, then spent four years in Switzerland at the EPFL performing postdoctoral research in the laboratories of Prof. Jeffrey Hubbell and Prof. Melody Swartz, as a Whitaker International Scholar.
Scott gained a decade of experience at Northwestern University, where he led innovative research and teaching as Kay Davis Professor of Biomedical Engineering & Microbiology-Immunology. Scott brings extensive expertise in biomaterials science, nanotechnology, and tissue engineering. His work, which has received substantial funding from the National Institutes of Health (NIH), focuses on developing advanced immunotherapies.
At UVA, Scott will hold dual appointments, including roles within the School of Medicine. He will also support the UVA Cancer Center and aim to promote interdisciplinary collaborations across the university.
Education
B.S. Biomedical Engineering, Brown University, 2002
Ph.D. Biomedical Engineering, Washington University in St. Louis, 2009